OVB.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 11:04):

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions...

Stats
Today's Volume	1.19M
Average Volume	359 766
Market Cap	734 074
EPS	£-0.00590 ( 2019-06-29 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-0.450
ATR14	£0.0570 (6.33%)

Ovoca Bio PLC Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ovoca Bio PLC Financials

Annual	2022
Revenue:	£0
Gross Profit:	£0 (0.00 %)
EPS:	£-0.0688

FY	2022
Revenue:	£0
Gross Profit:	£0 (0.00 %)
EPS:	£-0.0688

FY	2021
Revenue:	£0.00
Gross Profit:	£0.00 (0.00 %)
EPS:	£-0.0671

FY	2020
Revenue:	£0.00
Gross Profit:	£0.00 (0.00 %)
EPS:	£-0.0286

Financial Reports:

No articles found.

Ovoca Bio PLC Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Ovoca Bio PLC

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.